Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
VivoSim Labs, Inc. specializes in providing testing services using 3D human tissue models of liver and intestine for drug safety and toxicology assessment. The company develops and offers bespoke toxicology insights, supporting pharmaceutical and biotech clients throughout drug development. Leveraging proprietary bioprinting and tissue engineering technologies, VivoSim aims to reduce drug development risks and costs, with a focus on non-animal testing methodologies and advanced disease models.
This description was generated via AI from an annual report. Updated about 1 year ago.